This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Kevin Muthurania: Innovator in Anti-CTLA-4 Antibody Compositions
Introduction
Kevin Muthurania is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-CTLA-4 antibody compositions. His work focuses on innovative treatments for various neoplasia conditions.
Latest Patents
Kevin holds a patent for "Anti-CTLA-4 antibody compositions." This invention provides novel compositions of anti-CTLA-4 antibodies that include a chelating agent. The patent outlines methods for treating diseases and conditions using these innovative compositions.
Career Highlights
Kevin Muthurania is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development in the field of antibody therapies, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Kevin has collaborated with esteemed colleagues, including Justin Abate and Sandeep Nema. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Kevin Muthurania's work in anti-CTLA-4 antibody compositions exemplifies the impact of innovative research in biotechnology. His contributions are paving the way for new treatment options in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile